Global Molecular Cytogenetics Market Size & Outlook

The global molecular cytogenetics market size was estimated at USD 2,397.8 million in 2024 and is projected to reach USD 6,391.0 million by 2033, growing at a CAGR of 11.7% from 2025 to 2033.
Revenue, 2024 (US$M)
$2,397.8
Forecast, 2033 (US$M)
$6,391.0
CAGR, 2025 - 2033
11.7%
Report Coverage
Worldwide

Global molecular cytogenetics market highlights

  • The global molecular cytogenetics market generated a revenue of USD 2,397.8 million in 2024 and is expected to reach USD 6,391.0 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 11.7% by 2033.
  • In terms of segment, oncology accounted for a revenue of USD 1,049.4 million in 2024.
  • Personalized Medicine is the most lucrative application segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 2,397.8 million
Market revenue in 2033USD 6,391.0 million
Growth rate11.7% (CAGR from 2025 to 2033)
Largest segmentOncology
Fastest growing segmentPersonalized Medicine
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationGenetic Disorders, Oncology, Personalized Medicine, Other

Other key industry trends

  • In terms of revenue, the North America accounted for 46.0% of the global molecular cytogenetics market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, China is the fastest growing regional market and is projected to reach USD 480.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Cytogenetics Market Scope

Molecular cytogenetics market segmentation & scope
Genetic Disorders
Oncology
Personalized Medicine
Other
Instruments
Consumables
Software & Services
Clinical & Research Laboratories
Hospitals & Path Labs
Academic Research Institutes
Pharmaceutical & Biotech Companies
Others
aCGH
sCGH
FISH
Immunohistochemistry
Spectral
Virtual
Others

Molecular Cytogenetics Market Companies

Name Profile # Employees HQ Website
MetaSystems View profile 11-50 Newton, Massachusetts, United States, North America https://metasystems-international.com/us/
BioView View profile 1-10 Rehovot, HaMerkaz, Israel, Asia http://www.bioview.co.il/HTMLs/Home.aspx
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Revvity Inc View profile 11500 940 Winter Street, Waltham, MA, United States, 02451 https://www.revvity.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Global molecular cytogenetics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 43.77% in 2024. Horizon Databook has segmented the Global molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Molecular Cytogenetics Application Outlook (Revenue, USD Million, 2021-2033)
    • Genetic Disorders
    • Oncology
    • Personalized Medicine
    • Other
  • Global Molecular Cytogenetics Product Outlook (Revenue, USD Million, 2021-2033)
    • Instruments
    • Consumables
    • Software & Services
  • Global Molecular Cytogenetics End Use Outlook (Revenue, USD Million, 2021-2033)
    • Clinical & Research Laboratories
    • Hospitals & Path Labs
    • Academic Research Institutes
    • Pharmaceutical & Biotech Companies
    • Others
  • Global Molecular Cytogenetics Technology Outlook (Revenue, USD Million, 2021-2033)
    • Comparative Genomic Hybridisation
      • aCGH
      • sCGH
    • FISH
    • Immunohistochemistry
    • Karyotyping
      • Spectral
      • Virtual
    • Others

Reasons to subscribe to Global molecular cytogenetics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global molecular cytogenetics market databook

  • Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global molecular cytogenetics market , including forecasts for subscribers. This global databook contains high-level insights into Global molecular cytogenetics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global molecular cytogenetics market size, by regions, 2021-2033 (US$M)

Top 10 countries: Molecular cytogenetics market size, 2020 (US$M)

Global molecular cytogenetics market share, by application, 2020 & 2028 (%, US$M)

Molecular cytogenetics market: Opportunity assessment by country

Global molecular cytogenetics market, by region, 2024 (US$M)

Global molecular cytogenetics market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online